Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …

Background The risk of mother‐to‐child transmission of hepatitis B virus (HBV) has been
quoted as 70–90% among women positive for hepatitis B surface antigen (HB sAg) and e …

Human immunodeficiency virus (HIV), Hepatitis B (HBV) and Hepatitis C (HCV) are blood-
borne viruses with potentially shared routes of transmission. In high-income settings, the …

Summary Background Sub-Saharan Africa is highly endemic for hepatitis B virus (HBV);
historically, most people were exposed during childhood through vertical or horizontal …

Hepatitis B virus (HBV)(sub) genotypes A1, D3 and E circulate in sub-Saharan Africa, the
region with one of the highest incidences of HBV-associated hepatocellular carcinoma …

Background Burkina-Faso's HIV/AIDS program is one of the most successful in Africa, with a
declining HIV prevalence and treatment outcomes that rival those of developed countries …

Background: Screening people living with HIV for hepatitis B virus (HBV) co-infection is
recommended in resource-rich settings to optimize HIV antiretroviral therapy (ART) and …

Stigma has grave consequences for persons living with HIV/AIDS. Stigma hampers
prevention of HIV transmission to sexual partners and to unborn babies, diagnosis, and …

Abstract Background Hepatitis B virus (HBV) infection was long considered an important
public health concern in Burkina Faso and still represents a major cause of liver cancer and …

Hepatitis B virus (HBV) is a significant public health issue that has not been adequately
addressed, especially in the high-prevalence region of Africa. Despite the incorporation of …